(January 16 17:02) World.einnews.com
CognivAiD provides a long-awaited option to fulfil the unmet needs of patients with vascular dementia.
CognivAiD demonstrated significant and clinically meaningful disease-modifying benefits in clinical trials based on VaDAS-Cog and ADCS-CGIC scales, with …
You can find the original article
here